Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8134 USD | +6.40% | +10.43% | -60.13% |
04-15 | Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform | CI |
04-02 | Top Midday Decliners | MT |
Sales 2024 * | 35.6M 2.85B | Sales 2025 * | 64.31M 5.15B | Capitalization | 86.54M 6.93B |
---|---|---|---|---|---|
Net income 2024 * | -134M -10.73B | Net income 2025 * | -132M -10.57B | EV / Sales 2024 * | 3.97 x |
Net Debt 2024 * | 54.84M 4.39B | Net Debt 2025 * | 63.58M 5.09B | EV / Sales 2025 * | 2.33 x |
P/E ratio 2024 * |
-0.76
x | P/E ratio 2025 * |
-0.86
x | Employees | 231 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.7% |
Latest transcript on Gritstone bio, Inc.
1 day | +6.40% | ||
1 week | +10.43% | ||
Current month | -68.35% | ||
1 month | -68.59% | ||
3 months | -70.42% | ||
6 months | -58.29% | ||
Current year | -60.13% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 31/07/15 |
Director of Finance/CFO | 44 | 22/06/21 | |
Karin Jooss
CTO | Chief Tech/Sci/R&D Officer | 59 | 12/04/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Allen
FOU | Founder | 57 | 31/07/15 |
Elaine Jones
CHM | Chairman | 69 | 11/09/19 |
Lawrence Corey
BRD | Director/Board Member | 77 | 11/08/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.8134 | +6.40% | 1,112,845 |
25/04/24 | 0.7645 | -5.95% | 1,068,630 |
24/04/24 | 0.8129 | +10.06% | 1,886,214 |
23/04/24 | 0.7386 | -0.93% | 2,411,711 |
22/04/24 | 0.7455 | +1.21% | 3,390,234 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.13% | 86.54M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- GRTS Stock